A research scientist at a laboratory of a pharmaceutical company in US. Reuters
Novartis is buying dry-eye medicine brand ‘Xiidra’ from Takeda Pharmaceutical for up to $5.3 billion as the Swiss pharma-maker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal calls for $3.4 billion up front and milestone payments up to $1.9 billion, Novartis said.
South Africa’s Biovac Institute will start local production of Sanofi’s Hexaxim vaccine next year and Pfizer’s anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.
Swiss drugmaker Novartis on won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million. The Food and Drug Administration approved Zolgensma for children
The Department of Health-Abu Dhabi decided to withdraw 20 batches medical products used in catheterisation and other healthcare operations from the Emirate because of their possibility of causing serious infection to patients if they were not immediately substituted with good ones.
The agenda for the meeting includes coming up with a plan to change the effects of the pandemic-hit year which made the industry cut production output.
Full-time operations staff in the United States who are employed by Amazon from Dec.1 to Dec.31 will receive a bonus of $300, while those in part-time roles will get $150.
World stocks remained on course for their best month ever on Friday as recent vaccine progress, Joe Biden’s US presidential election win, hopes for further stimulus, a commodity surge and descending dollar all lifted the spirits.
Ras Al Khaimah: Ras Al Khaimah International Airport (RAK Airport) on Friday welcomed the first scheduled SpiceJet passenger flight, with the aircraft’s arrival heralding the commencement of both a new phase of operations for the UAE transport